Lawsuits allege GLP-1 drugs like Ozempic cause serious eye damage including optic neuropathy, but causation remains unclear. Todd Engel lost vision in both eyes after taking Ozempic for diabetes, and over 1,000 adverse reports link GLP-1s to optic neuropathy, though the FDA has not yet required label changes and more research is needed.